Article
[Clinical Management of HBOC in Our Hospital].
Gan to kagaku ryoho. Cancer & chemotherapy - 1 Feb 2017
Nomura Hidetaka, Takeshima Nobuhiro
Abstract excerpt
The cumulative risks of developing epithelial ovarian cancer in women aged 70-75years with BRCA1 and BRCA2 germline mutations are approximately 39-40% and 11-18%, respectively. Here, we present the management of hereditary breast and ovarian cancer(HBOC)in our hospital. HBOC management commences with the selection of appropriate candidates for genetic testing, based on personal and familial characteristics that...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
